Skip to main content
NCBI home page
Nature Portfolio logoLink to Nature Portfolio
. 2026 Jan 28;32(2):763. doi: 10.1038/s41591-026-04233-9

Author Correction: Intrathecal onasemnogene abeparvovec for treatment-experienced patients with spinal muscular atrophy: a phase 3b, open-label trial

Jennifer M Kwon 1,✉, Francina Munell 2, Laure Le Goff 3, Kotaro Yuge 4, Tamaki Kato 5, Claude Cances 6, Liesbeth De Waele 7,8, Ian R Woodcock 9,10, Eugenio M Mercuri 11,12, Crystal M Proud 13, Basil T Darras 14, Leslie H Hayes 14, Maryam Oskoui 15,16, Jeannie Visootsak 17, Gemma Williams 18, Andreja Ilić 19, Lina Yang 17, W Ludo van der Pol 20
PMCID: PMC12920092  PMID: 41606122

Correction to: Nature Medicine 10.1038/s41591-025-04119-2, published online 8 December 2025.

In the version of the article initially published, in the second paragraph of the “Safety” section, the text “one on the day of gastronomy surgery” has been amended to “one on the day of percutaneous endoscopic gastrostomy” in the HTML and PDF versions of the article.

Articles from Nature Medicine are provided here courtesy of Nature Publishing Group

RESOURCES